Anaphylaxis Treatment Market: By Drug Class (Epinephrine, Steroids, Antihistamines, Beta-antagonists, Others), By Route of Administration (Oral, Parenteral, Others), By Application (Food Allergy, Pollen Allergy, Dust Mites Allergy, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Anaphylaxis Treatment Market size was valued at USD 3,104.4 million in 2022 and is expected to grow at an 8.9% CAGR from 2023 to 2029. Anaphylaxis is a serious allergic condition that may cause even death of the patients. Throat swelling, vomiting, shortness of breath, itchy rash, and low blood screening pressure are some symptoms of anaphylaxis. Insect bites, unwanted food consumption, and medications are some of the causes of anaphylaxis. The increasing number of allergic patients across the globe is expected to drive the growth of the anaphylaxis treatment market. For instance, about 150 million Europeans are affected by chronic allergies each year and according to the National Institute of Healthcare Excellence, more than 20 people die in the UK owing to improper treatment of anaphylaxis. In addition, increasing research and development of anti-anaphylaxis drug quality and increasing anaphylaxis treatment market demand for self-administration treatment are anticipated to boost the growth of the anaphylaxis treatment market. Furthermore, increasing awareness about the treatment of anaphylaxis, increasing geriatric population, and rising overuse of medicines in rural areas is anticipated to have a positive impact on the growth of the anaphylaxis treatment market over the forecast period. However, side effects caused by the administration of epinephrine and steroids, and lack of knowledge in developing countries is expected to hinder the growth of anaphylaxis treatment market. Moreover, increasing investments in many countries, and increasing government support in lowering the treatment cost and increasing product approvals are anticipated to provide opportunities to the manufacturers and market players in the growth of anaphylaxis treatment market over the forecast period. 

Anaphylaxis Treatment Market Key Developments:
  • In March 2022, Aquestive Therapeutics Inc. announced their USFDA approval of AQST-109, the first orally delivered epinephrine-based drug for the emergency treatment of allergic reactions.

Global Anaphylaxis Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

8.9%

Largest Market

North America

Fastest Growing Market

North America
Anaphylaxis Treatment Market Dynamics

The anaphylaxis treatment market is expected to grow over the forecasted period owing to the increasing incidence of allergies and anaphylaxis. For instance, according to the Centre for Disease Control and Prevention, the prevalence of food allergies in children under 18 years has risen by 50% in the last two decades in the US. Thus, this increasing incidence of anaphylaxis is expected to increase the demand for effective and convenient anaphylaxis treatment. In addition, increasing awareness of treatment and increasing research and development has resulted in innovation of new pipeline drugs. Thus, these factors are expected to drive the growth of the anaphylaxis treatment market over the forecast period.

Key Features of the Reports

  • The anaphylaxis treatment market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Anaphylaxis Treatment Market Segmentation

By Drug Class
  • Epinephrine
  • Steroids
  • Antihistamines
  • Beta-antagonists
  • Others
By Route of Administration
  • Oral
  • Parenteral
  • Others
By Application
  • Food Allergy
  • Pollen Allergy
  • Dust Mites Allergy
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacie
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The anaphylaxis treatment market size was valued at USD 3,104.4 million in 2022

The anaphylaxis treatment market key players are: Pfizer Inc. Mylan N.V GlaxoSmithKline Plc Amneal Pharmaceuticals Merck & Co Inc Teva Pharmaceutical Industries ltd. Adamis Pharmaceutical Corporation Abbott Laboratories Sandoz Inc. Aquestive Therapeutics Inc. Amphastar Pharmaceuticals Inc.

The anaphylaxis treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1.Executive Summary
2.Global Anaphylaxis Treatment Market Introduction 
2.1.Global Anaphylaxis Treatment Market  - Taxonomy
2.2.Global Anaphylaxis Treatment Market  - Definitions
2.2.1.Drug Class
2.2.2.Route of Administration
2.2.3.Application
2.2.4. Distribution Channel
2.2.5.Region
3.Global Anaphylaxis Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Anaphylaxis Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Anaphylaxis Treatment Market  By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Epinephrine
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Steroids
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Antihistamines
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Beta-antagonists
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Anaphylaxis Treatment Market  By Route of Administration, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Parenteral
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Low Tension Glaucoma
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Anaphylaxis Treatment Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Food Allergy
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Pollen Allergy
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Dust Mites Allergy
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Anaphylaxis Treatment Market  By  Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacie
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Anaphylaxis Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Epinephrine
10.1.2.Steroids
10.1.3.Antihistamines
10.1.4.Beta-antagonists
10.1.5.Others
10.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Parenteral
10.2.3.Others
10.2.4.Low Tension Glaucoma
10.2.5.Others
10.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Food Allergy
10.3.2.Pollen Allergy
10.3.3.Dust Mites Allergy
10.3.4.Others
10.4.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies
10.4.2.Retail Pharmacies
10.4.3.Online Pharmacie
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Epinephrine
11.1.2.Steroids
11.1.3.Antihistamines
11.1.4.Beta-antagonists
11.1.5.Others
11.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Parenteral
11.2.3.Others
11.2.4.Low Tension Glaucoma
11.2.5.Others
11.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Food Allergy
11.3.2.Pollen Allergy
11.3.3.Dust Mites Allergy
11.3.4.Others
11.4.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies
11.4.2.Retail Pharmacies
11.4.3.Online Pharmacie
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Epinephrine
12.1.2.Steroids
12.1.3.Antihistamines
12.1.4.Beta-antagonists
12.1.5.Others
12.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Parenteral
12.2.3.Others
12.2.4.Low Tension Glaucoma
12.2.5.Others
12.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Food Allergy
12.3.2.Pollen Allergy
12.3.3.Dust Mites Allergy
12.3.4.Others
12.4.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies
12.4.2.Retail Pharmacies
12.4.3.Online Pharmacie
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Epinephrine
13.1.2.Steroids
13.1.3.Antihistamines
13.1.4.Beta-antagonists
13.1.5.Others
13.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Parenteral
13.2.3.Others
13.2.4.Low Tension Glaucoma
13.2.5.Others
13.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Food Allergy
13.3.2.Pollen Allergy
13.3.3.Dust Mites Allergy
13.3.4.Others
13.4.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies
13.4.2.Retail Pharmacies
13.4.3.Online Pharmacie
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Epinephrine
14.1.2.Steroids
14.1.3.Antihistamines
14.1.4.Beta-antagonists
14.1.5.Others
14.2.  Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Oral
14.2.2.Parenteral
14.2.3.Others
14.2.4.Low Tension Glaucoma
14.2.5.Others
14.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Food Allergy
14.3.2.Pollen Allergy
14.3.3.Dust Mites Allergy
14.3.4.Others
14.4.   Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies
14.4.2.Retail Pharmacies
14.4.3.Online Pharmacie
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Pfizer Inc.
15.2.2.Mylan N.V
15.2.3.GlaxoSmithKline Plc
15.2.4.Amneal Pharmaceuticals
15.2.5.Merck & Co Inc
15.2.6.Teva Pharmaceutical Industries ltd.
15.2.7.Adamis Pharmaceutical Corporation
15.2.8.Abbott Laboratories
15.2.9.Sandoz Inc.
15.2.10.Aquestive Therapeutics Inc.
15.2.11.Amphastar Pharmaceuticals Inc.
16. Research Methodology 
17. Appendix and Abbreviations 
  • Pfizer Inc.
  • Mylan N.V
  • GlaxoSmithKline Plc
  • Amneal Pharmaceuticals
  • Merck & Co Inc
  • Teva Pharmaceutical Industries ltd.
  • Adamis Pharmaceutical Corporation
  • Abbott Laboratories
  • Sandoz Inc.
  • Aquestive Therapeutics Inc.
  • Amphastar Pharmaceuticals Inc.